search
Back to results

Effect of GABA on ADHD and Seizures in Children With Epilepsy.

Primary Purpose

Epilepsy

Status
Recruiting
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
GABA
Sponsored by
Sherief Abd-Elsalam
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Epilepsy

Eligibility Criteria

4 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Epilepsy
  • ADHD

Exclusion Criteria:

  • Epilepsy without ADHD

Sites / Locations

  • Sherief Abd-ElsalamRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Before treatment

After treatment

Arm Description

no intervention

GABA

Outcomes

Primary Outcome Measures

Number of seizures
Number of seizures

Secondary Outcome Measures

Full Information

First Posted
October 4, 2019
Last Updated
October 29, 2019
Sponsor
Sherief Abd-Elsalam
search

1. Study Identification

Unique Protocol Identification Number
NCT04144439
Brief Title
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
Official Title
Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2018 (Actual)
Primary Completion Date
December 1, 2028 (Anticipated)
Study Completion Date
December 1, 2028 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Sherief Abd-Elsalam

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Effect of GABA on ADHD and seizures in Children with epilepsy.
Detailed Description
Effect of Gamma aminobutyric acid on ADHD and seizures in Children with epilepsy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Epilepsy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Before treatment
Arm Type
No Intervention
Arm Description
no intervention
Arm Title
After treatment
Arm Type
Active Comparator
Arm Description
GABA
Intervention Type
Drug
Intervention Name(s)
GABA
Other Intervention Name(s)
Gamma amino butyric acid
Intervention Description
Gamma amino butyric acid
Primary Outcome Measure Information:
Title
Number of seizures
Description
Number of seizures
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Epilepsy ADHD Exclusion Criteria: Epilepsy without ADHD
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sherief Abd-Elsalam, ass. prof.
Phone
00201147773440
Email
sheriefabdelsalam@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
sherief abd-elsalam, ass. prof.
Phone
00201147773440
Email
sherif_tropical@yahoo.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Abeer Salamah, Lecturer
Organizational Affiliation
Lecturer of Pediatrics - Kafr Elsheikh University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sherief Abd-Elsalam
City
Tanta
ZIP/Postal Code
35111
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Abeer Salamah, Msc
Phone
00201009221243

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of GABA on ADHD and Seizures in Children With Epilepsy.

We'll reach out to this number within 24 hrs